Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.

The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the ...

Former seven-time Mr. Olympia champion Arnold Schwarzenegger discussed the strength and endurance benefits of caffeinated ...

A large clinical trial suggests vitamin D may slow biological aging by preserving telomeres. Findings from the VITAL randomized controlled trial show that vitamin D supplementation can help preserve ...

Novo Nordisk may pursue layoffs as its new CEO focuses on efficiency while facing intensifying obesity drug competition.

In adults with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, the ...

The FDA has approved Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of fibromyalgia in adults.

The Food and Drug Administration has granted Fast Track designation to CELZ-201-DDT for the treatment of degenerative disc disease.

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...

Poor oral bacteria may hinder blood pressure benefits, but Exeter study finds beetroot juice’s nitrates restore balance, ...

Celldex has stopped development of barzolvolimab in eosinophilic esophagitis (EoE) despite meeting its primary endpoint in a ...